Skip to main content

Table 1 Clinical and pathological patient characteristics

From: Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction

 

All

Hydronephrosis stratification at 1 M

P value

Control

Low

Intermediate

High

n

64

12

11

27

14

 

Agea

66 (61–71)

63 (55–69)

69 (60–73)

67 (59–71)

69 (63–75)

0.401 b

Gender (Male/Female), n=

48 / 16

     

ECOG-PS

0.0 (0–0)

0.0 (0–0)

0.0 (0–0)

0.0 (0–0)

0.0 (0–0)

1.000 b

Past history, n=

 Cardiovascular disease

6 (9%)

1 ((%)

1 (9%)

3 (11%)

1 (7%)

1.000 c

 Hypertension

21 (33%)

3 (25%)

3 (27%)

11 (41%)

4 (29%)

0.765 c

 Diabetes

9 (14%)

1 (8%)

2 (18%)

5 (19%)

1 (7%)

0.729 c

Neoadjuvant chemotherapy, n=

61 (95%)

11 (92%)

11 (100%)

26 (96%)

13 (93%)

0.882 c

Clinical T stagea

2 (2–3)

3 (2–3)

2 (2–3)

2 (2–3)

3 (2–3)

0.580 b

Pathological T stagea

1 (0–2)

2 (0–2)

1 (0–2)

2 (1–2)

2 (0–2)

0.578 b

Pathological N+, n=

2 (3%)

0 (0%)

0 (0%)

1 (4%)

1 (7%)

1.000 c

eGFRa

 Before surgery

73 (66–87)

77 (75–97)

84 (73–91)

72 (65–88)

69 (62–73)

0.062 b

 1 month after surgery

60 (53–74)

71 (57–82)

73 (60–88)

58 (52–65)

56 (43–72)

0.029 b

 1 year after surgery

65 (56–74)

69 (62–76)

63 (53–78)

63 (53–74)

69 (61–75)

0.524 b

Hydronephrosis gradesa

 Before surgery

0 (0–0)

0 (0–1)

0 (0–0)

0 (0–0)

0 (0–0)

0.348 b

 1 month after surgery

2 (0–2)

0 (0–0)

1 (0–2)

2 (2–2)

3 (3–3)

< 0.001 b

 1 year after surgery

0 (0–1)

0 (0–0)

0 (0–1)

0 (0–0)

1 (0–1)

0.021 b

 Complications (any grades), n=

16 (25%)

2 (17%)

3 (27%)

10 (37%)

1 (7%)

0.213c

 Complications (Clavien Grade > 3), n=

2 (2%)

0 (0%)

1 (9%)

1 (4%)

0 (0%)

0.261b

 Operative durationa (min)

294 (266–323)

281 (237–303)

277 (263–300)

322 (273–356)

280 (265–307)

0.015 b

 Blood lossa (g)

1380 (1034–2302)

1345 (576–2211)

1400 (1070–2465)

1470 (926–2350)

1430 (1095–2359)

0.914 b

 Recurrence (within 1 year), n=

2 (3%)

0 (0%)

2 (18%)

0 (0%)

0 (0%)

0.813 c

  1. amedian (Q1-Q3)
  2. Q1, first quartile; Q3, third quartile;b Kruskal–Wallis test;c Fisher’s exact test